• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Lot Number 0023303054
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Pericardial Effusion (3271)
Event Date 06/13/2019
Event Type  Death  
Manufacturer Narrative
(b)(6).
 
Event Description
It was reported a pericardial effusion and patient death occurred.A left atrial appendage (laa) closure procedure was being performed.The patient was on eliquis.The trans-septal puncture was performed and 8000 units of heparin were administered.A watchman truseal access system (was) was positioned into the laa with a pigtail catheter.Contrast injections and transesophageal echocardiogram measurements were performed.A 21mm watchman laa closure device and delivery system (wds) was advanced into the was.At this time, the operating table was repositioned to get a better view of the laa anatomy.The closure device was deployed, but it was too deep in the laa, so a partial recapture was performed.The closure device was deployed again but was still too deep in the laa.Angiography revealed contrast in the pericardium.The patient was hemodynamically stable, so the procedure continued.A partial recapture was performed and the closure device was redeployed in correct position.The release criteria were met, so the closure device was successfully implanted.The size of the pericardial effusion was.9cm.The physician decided to perform a pericardiocentesis.The blood was aspirated via the pigtail catheter and re-infused into the patient.The activated clotting time was measured at 177 seconds.The bleeding did not stop, so the patient was transferred to cardiac surgery and was hemodynamically stable.Surgery was successfully performed.The closure device was removed and the laa was ligated.After the procedure, the physician reviewed the angiography images and believed it was the was that probably injured the laa wall while the operating table was moved.One day post procedure, the patient died of kidney failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN TRUSEAL ACCESS SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key8780522
MDR Text Key150703148
Report Number2134265-2019-07792
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 07/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/05/2022
Device Lot Number0023303054
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/13/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/06/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-